Dr. Bobby Dean Peterson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2390 Jackson Ave, Escalon, CA 95320 Phone: 209-838-6015 Fax: 209-838-0750 |
News Archive
XenoPort, Inc. announced today preliminary top-line results of a Phase 2, randomized, crossover clinical trial that compared optimized treatment with either Sinemet (immediate-release levodopa/carbidopa) or XP21279 co-formulated with carbidopa (279/CD) in advanced Parkinson's disease patients with motor fluctuations.
Cegedim Dendrite, the world's leading provider of pharmaceutical-specific Customer Relationship Management solutions, and Capgemini U.S. LLC ("Capgemini"), one of the world's foremost providers of consulting, technology and outsourcing services, announced an alliance to jointly offer software solutions, consulting and technology services around aggregate spend and customer master data to Life Sciences companies. Through the alliance, Capgemini will provide broad based consulting and implementation services associated with Cegedim Dendrite's AggregateSpend360™ and Nucleus 360™ solutions to pharmaceutical, biotech and medical device companies.
Heavy alcohol drinkers attempt to acquire alcohol despite the threat of a negative consequence more so than light drinkers, a study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging has found, and this behavior is associated with unique activation of brain circuitry in heavy drinkers.
Can meditation, yoga or mindfulness training help nurses and teachers be more effective and resilient in stressful situations? Can such contemplative practices be part of a more effective treatment regimen for major depression, or for alcoholics in recovery?
The Pennsylvania Patient Safety Authority has collected over one million reports from Pennsylvania healthcare facilities since June 2004. Ninety-six percent of the events are near misses or events that did not cause harm to the patient.
› Verified 7 days ago